b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Data-Review" Owner="NLM">\n        <PMID Version="1">32165377</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>16</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1468-330X</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>91</Volume>\n                    <Issue>5</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>May</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of neurology, neurosurgery, and psychiatry</Title>\n                <ISOAbbreviation>J. Neurol. Neurosurg. Psychiatry</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Predictors of outcome in 1-month survivors of large middle cerebral artery infarcts treated by decompressive hemicraniectomy.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>469-474</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2019-322280</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Decompressive hemicraniectomy (DH) increases survival without severe dependency in patients with large middle cerebral artery (LMCA) infarcts. The objective was to identify predictors of 1-year outcome after DH for LMCA infarct.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted this study in consecutive patients who underwent DH for LMCA infarcts, in a tertiary stroke centre. Using multivariable logistic regression analyses, we evaluated predictors of (1) 30-day mortality and (2) poor outcome after 1\xe2\x80\x89year (defined as a modified Rankin Scale score of 4-6) in 30-day survivors.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 212 patients (133 men, 63%; median age 51 years), 35 (16.5%) died within 30 days. Independent predictors of mortality were infarct volume before DH (OR 1.10 per 10\xe2\x80\x89mL increase, 95% CI 1.04 to 1.16), delay between symptom onset and DH (OR 0.41, 95%\xe2\x80\x89CI 0.23 to 0.73 per 12\xe2\x80\x89hours increase) and midline shift after DH (OR 2.59, 95%\xe2\x80\x89CI 1.09 to 6.14). The optimal infarct volume cut-off to predict death was 210\xe2\x80\x89mL or more. Among the 177 survivors, 77 (43.5%) had a poor outcome at 1\xe2\x80\x89year. Independent predictors of poor outcome were age (OR 1.08 per 1\xe2\x80\x89year increase, 95%\xe2\x80\x89CI 1.03 to 1.12) and weekly alcohol consumption of 300\xe2\x80\x89g or more (OR 5.30, 95%\xe2\x80\x89CI 2.20 to 12.76), but not infarct volume.</AbstractText>\n                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In patients with LMCA infarcts treated by DH, stroke characteristics (infarct volume before DH, midline shift after DH and early DH) predict 30-day mortality, while patients\' characteristics (age and excessive alcohol intake) predict 1-year outcome survivors.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Casolla</LastName>\n                    <ForeName>Barbara</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Neurology, Stroke Unit, CHU Lille, Inserm U1171, Lille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kyheng</LastName>\n                    <ForeName>Maeva</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Statistics, CHU Lille, Lille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kuchcinski</LastName>\n                    <ForeName>Gregory</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Neuroradiologie, CHU Lille, Lille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lejeune</LastName>\n                    <ForeName>Jean-Paul</ForeName>\n                    <Initials>JP</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Neurosurgery, CHU Lille, Lille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hanafi</LastName>\n                    <ForeName>Riyad</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Neuroradiologie, CHU Lille, Lille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bodenant</LastName>\n                    <ForeName>Marie</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Neurology, CHU Lille, Lille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Leys</LastName>\n                    <ForeName>Didier</ForeName>\n                    <Initials>D</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4408-4392</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Neurology, Stroke Unit, CHU Lille, Inserm U1171, Lille, France didier.leys@univ-lille.fr.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Labreuche</LastName>\n                    <ForeName>Julien</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Statistics, CHU Lille, Lille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Allart</LastName>\n                    <ForeName>Etienne</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Rehabilitation centre, CHU Lille, Lille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Jourdain</LastName>\n                    <ForeName>Merce</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Intensive Care Unit, CHU Lille, Lille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cordonnier</LastName>\n                    <ForeName>Charlotte</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Neurology, Stroke Unit, CHU Lille, Inserm U1171, Lille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Henon</LastName>\n                    <ForeName>Hilde</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Neurology, Stroke Unit, CHU Lille, Inserm U1171, Lille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2020</Year>\n                <Month>03</Month>\n                <Day>12</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA>\n            <NlmUniqueID>2985191R</NlmUniqueID>\n            <ISSNLinking>0022-3050</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <CoiStatement>Competing interests: DL reports participation in symposia organised by Boehringer Ingelheim, Bayer, BMS and Pfizer (honoraria paid to Adrinord), drug trials with Boehringer-Ingelheim (honoraria paid to the hospital); he is vice editor of the European Stroke Journal (honoraria paid to Adrinord), vice president of the scientific committee of the Fondation de Recherche sur les AVC (unpaid); is a member of the scientific committee of the Servier Institute (unpaid); and was member of DSMBs for institutional trials (unpaid) (INCH, Germany; TARDIS, United Kingdom; and TO-ACT, the Netherlands). He received research support from a grant of the University of Heidelberg (Germany) for the ECASS4 trial. CC served for advisory boards (Bayer, Medtronics and Daiichi-Sankyo) and as investigator for clinical trials (Astra-Zeneca, Boehringer-Ingelheim, Daiichi-Sankyo and Pfizer). All fees were paid to ADRINORD or the Lille University Hospital research account; no personal funding.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>04</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2020</Year>\n                <Month>01</Month>\n                <Day>22</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>3</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>3</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>3</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">32165377</ArticleId>\n            <ArticleId IdType="pii">jnnp-2019-322280</ArticleId>\n            <ArticleId IdType="doi">10.1136/jnnp-2019-322280</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'